EOCRCPred: an AI Model to Predict Survival in EOCRC Patients After Surgery

Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-49
SponsorShanghai University of Traditional Chinese Medicine

About this trial

The goal of this observational study is to develop a predictive model for overall survival in patients under the age of 50 who have undergone surgery for early-onset colorectal cancer (EOCRC). The main question it aims to answer is:

Can machine learning models accurately predict the long-term survival of EOCRC patients after surgical treatment?

Participants who have already undergone surgery for EOCRC as part of their regular medical care will have their clinical data analyzed, with survival outcomes tracked through follow-up assessments. An online survival calculator will also be developed to aid clinicians and patients in predicting personalized survival outcomes.

Eligibility criteria

Qualifiers

Primary EOCRC confirmed by pathological histological examination (ICD-10 codes: C18.0, C18.2-18.9, C19.9, C20.9)

Radical surgery performed (Specific Surgery Codes 30-70, including partial/subtotal colectomy, hemicolectomy, right/left colectomy, and total colectomy, as well as partial or total removal of other organs and regional lymph nodes)

Stage I-III disease according to the 7th AJCC-TNM system

Disqualifiers

Patients with multiple primary cancers or other malignancies

Survival time of less than 1 month, or absence of postoperative follow-up information

Incomplete critical clinical feature information

Trial design

Treatments tested in this trial

  • Not listed

Trial groups

250 Participants
are grouped into 1 trial group